141 related articles for article (PubMed ID: 7822205)
1. [Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].
Schallreuter KU; Lemke KR
Hautarzt; 1994 Nov; 45(11):783-6. PubMed ID: 7822205
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
Soto J; Hernandez N; Mejia H; Grogl M; Berman J
Clin Infect Dis; 1995 Jan; 20(1):47-51. PubMed ID: 7727669
[TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.
Arana BA; Mendoza CE; Rizzo NR; Kroeger A
Am J Trop Med Hyg; 2001 Nov; 65(5):466-70. PubMed ID: 11716099
[TBL] [Abstract][Full Text] [Related]
4. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
Soto J; Fuya P; Herrera R; Berman J
Clin Infect Dis; 1998 Jan; 26(1):56-8. PubMed ID: 9455509
[TBL] [Abstract][Full Text] [Related]
5. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study.
Krause G; Kroeger A
Clin Infect Dis; 1999 Aug; 29(2):466-7. PubMed ID: 10476776
[No Abstract] [Full Text] [Related]
6. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
Grogl M; Schuster BG; Ellis WY; Berman JD
J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
[TBL] [Abstract][Full Text] [Related]
7. Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador.
Krause G; Kroeger A
Trans R Soc Trop Med Hyg; 1994; 88(1):92-4. PubMed ID: 8154018
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
Armijos RX; Weigel MM; Calvopiña M; Mancheno M; Rodriguez R
Acta Trop; 2004 Jul; 91(2):153-60. PubMed ID: 15234664
[TBL] [Abstract][Full Text] [Related]
9. Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
el-On J; Sulitzeanu A; Schnur LF
Ann Trop Med Parasitol; 1991 Jun; 85(3):323-8. PubMed ID: 1746981
[TBL] [Abstract][Full Text] [Related]
10. Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.
el-On J; Weinrauch L; Livshin R; Even-Paz Z; Jacobs GP
Br Med J (Clin Res Ed); 1985 Sep; 291(6497):704-5. PubMed ID: 3929905
[No Abstract] [Full Text] [Related]
11. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.
Iraji F; Sadeghinia A
Ann Trop Med Parasitol; 2005 Jan; 99(1):3-9. PubMed ID: 15701249
[TBL] [Abstract][Full Text] [Related]
12. Topical treatment of cutaneous leishmaniasis.
El-On J; Livshin R; Even-Paz Z; Hamburger D; Weinrauch L
J Invest Dermatol; 1986 Aug; 87(2):284-8. PubMed ID: 3734476
[TBL] [Abstract][Full Text] [Related]
13. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
El-On J; Bazarsky E; Sneir R
Exp Parasitol; 2007 Jun; 116(2):156-62. PubMed ID: 17306255
[TBL] [Abstract][Full Text] [Related]
14. Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methyl benzethonium chloride and the aminoglycosides, gentamicin and paromomycin.
Carter KC; Alexander J; Baillie AJ
Ann Trop Med Parasitol; 1989 Jun; 83(3):233-9. PubMed ID: 2604461
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post-kala-azar dermal leishmaniasis: an observational pilot study.
Pandey K; Pal B; Das VNR; Murti K; Lal CS; Verma N; Bimal S; Ali V; Verma RB; Topno RK; Siddiqi NA; Das P
Br J Dermatol; 2017 Aug; 177(2):557-559. PubMed ID: 27781268
[No Abstract] [Full Text] [Related]
16. [Topical treatment of persistent cutaneous leishmaniasis with paromomycin].
Flaig MJ; Rupec J; Ruzicka T; Rupec RA
Hautarzt; 2007 Aug; 58(8):689-90, 692. PubMed ID: 17676349
[TBL] [Abstract][Full Text] [Related]
17. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
Weinrauch L; Cawich F; Craig P; Sosa JX; el-On J
J Am Acad Dermatol; 1993 Sep; 29(3):443-6. PubMed ID: 8349861
[TBL] [Abstract][Full Text] [Related]
18. Topical paromomycin for New World cutaneous leishmaniasis.
Sosa N; Pascale JM; Jiménez AI; Norwood JA; Kreishman-Detrick M; Weina PJ; Lawrence K; McCarthy WF; Adams RC; Scott C; Ransom J; Tang D; Grogl M
PLoS Negl Trop Dis; 2019 May; 13(5):e0007253. PubMed ID: 31048871
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
Stanimirović A; Stipić T; Skerlev M; Basta-Juzbasić A
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
[TBL] [Abstract][Full Text] [Related]
20. [Effect of a hydrophilic formulation of topical paromomycin on cutaneous leishmaniasis among patients with contraindications for treatment with pentavalent antimonials].
Santos AM; Noronha EF; Ferreira LA; Carranza-Tamayo CO; Cupolillo E; Romero GA
Rev Soc Bras Med Trop; 2008; 41(5):444-8. PubMed ID: 19009183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
